IBM is a technology service provider for Janssen. In particular, it oversees the administration of the CarePath application and database.
CarePath is a software program created to assist patients in obtaining Janssen medications, provide discounts and cost-saving tips on prescriptions, explain insurance eligibility, and provide drug refiling and administration reminders.
The pharmaceutical company learned about an undocumented technique that could provide unauthorized individuals access to the CarePath database, according to the notification on Janssen’s website.
Later, the company informed the issue to IBM that swiftly took action in patching the security gap and conducted an internal investigation to see whether the bug had been exploited by anyone.
The investigation wrapped up in August 2nd, 2023, and revealed that unauthorized persons had access to the following CarePath user details, that are as follows:
- Full name
- Contact information
- Date of birth
- Health insurance information
- Medication information
- Medical condition information
Users of CarePath who signed up for Janssen’s
[…]
Content was cut in order to protect the source.Please visit the source for the rest of the article.
Read the original article: